| Literature DB >> 16603061 |
Packianathan Thomas Muthiah1, Savarimuthu Francis, Urszula Rychlewska, Beata Warzajtis.
Abstract
BACKGROUND: Trimethoprim [2,4-diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidine] is an antifolate drug. It selectively inhibits the bacterial dihydrofolate reductase (DHFR) enzyme.Entities:
Year: 2006 PMID: 16603061 PMCID: PMC1470456 DOI: 10.1186/1860-5397-2-8
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1The schematic diagram for the various hydrogen-bonded motifs observed in compound (1).
Figure 2The schematic diagram for the various hydrogen-bonded motifs observed in compound (2).
Figure 3The ORTEP 3 view of the asymmetric unit of the compound 1.
Figure 4The ORTEP 3 view of the asymmetric unit of the compound 2.
Hydrogen bonding geometry for the compounds 1 and 2
| Compound | D-H...A | H...A | D...A | D-H...A |
| N4 - H3... O4a | 2.19(2) | 2.939(2) | 139.8(17) | |
| N2 - H6... O6b | 2.08(2) | 2.954(2) | 164(2) | |
| N4 - H9... N3c | 2.11(2) | 2.986(2) | 171(2) | |
| N2 - H10... O4d | 2.05(3) | 3.008(2) | 174(2) | |
| N2 - H10... O5 | 2.53(2) | 3.109(2) | 118.8(18) | |
| N1 - H11... O7 | 1.76(2) | 2.678(2) | 164.4(19) | |
| O5 - H16... O6 | 1.35(3) | 2.399(2) | 174(3) | |
| C21 - H5 ... O7 | 2.24(2) | 2.670(2) | 104.5(15) | |
| C24 - H8 ... O4 | 2.28(2) | 2.679(3) | 103.0(13) | |
| C15 - H25... O1 | 2.56(3) | 3.037(3) | 110(2) | |
| N1 - H5O ...O4e | 1.73(2) | 2.682(2) | 175(2) | |
| O7 - H7O... O4f | 1.65(4) | 2.555(2) | 169(3) | |
| N2 - H21... O5 | 1.95(2) | 2.841(2) | 179(3) | |
| N2 - H22...O5 | 2.04(3) | 2.833(2) | 143(2) | |
| N4 - H42...O6 | 2.08(3) | 2.951(3) | 168(2) | |
Symmetry Codes : a = -1+x, 1+y, z, b = 1+x, y, z, c = -x, 1-y, 1-z, d = 1-x, -y, 1-z, e = 2-x, 1-y, -z, f = -1+x, y, z
Crystallographic parameters for 1 and 2
| Properties | ||
| Formula | C14 H19 N4 O3+ | C14 H18 N4 O3+ |
| C8 H5 O4- | C6 H10 O4- | |
| M.wt | 456.45 | 436.46 |
| Crystal System | Triclinic | Triclinic |
| Space group | P-1 | P-1 |
| a/A° | 4.6510(10) | 8.172(2) |
| b/A° | 11.700(2) | 9.4744(8) |
| c/A° | 20.362(4) | 13.8162(8) |
| α/° | 76.21(3) | 85.741(6) |
| β/° | 86.23(3) | 87.430(10) |
| γ/° | 84.03(3) | 88.680(10) |
| V/A°3 | 1069.3(4) | 1065.5(3) |
| Z | 2 | 2 |
| Radiation α/A° | 1.54718 | 1.54718 |
| Dc/g cm-3 | 1.418 | 1.360 |
| T/K | 293(2) | 294(2) |
| μ/mm-1 | 0.900 | 0.870 |
| F(000) | 480 | 464 |
| Reflection collected | 4420 | 3706 |
| Observed data [I>2σ(I)] | 3137 | 3062 |
| Parameters refined | 395 | 404 |
| Final R1 on observed data | 0.0421 | 0.0439 |
| Final wR2 on observed data | 0.1246 | 0.1270 |
| Structure solution | SHELXS97 [36] | SHELXS97 |
| Structure refinement | SHELXL97 | SHELXL97 |
| Graphics | PLATON97 [37] | PLATON97 |
Figure 5The hydrogen-bonded supramolecular ladder in the compound 1.
Figure 6The hydrogen-bonded DDAA array in the compound 2.
Figure 7The supramolecular chain made up of hydrogen adipate in the compound 2.
Figure 8Scatterplot illustrating the distribution of the two torsion angles (C4-C5-C7-C8 (TOR1) and C5-C7-C8-C9 (TOR2)) that describe the mutual orientation of pyrimidine and phenyl rings in the TMP molecule. The torsion angle values were obtained from the July 2003 release of the 5.24 version of the CSD [32]. The values of TOR2 have been restricted to the range from -90 to +90°.